Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | CMO and VP, Medical Affairs | January 15, 2020 | January 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date January 15, 2020 · Filed January 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,170 |
Reported balance
After 2020-01-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-01-15 · Exercise / conversion · Acquired 5,000 · Balance 49,170 |
| Common StockSEC Table I · non-derivative | Direct | 44,170 |
Reported balance
After 2020-01-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-01-15 · Sale · Disposed 5,000 · Balance 44,170 F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.57, inclusive. F3: Includes 40,080 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.96 · Expires 2023-03-18 | Direct | 20,554 |
Reported balance
After 2020-01-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-01-15 · Exercise / conversion · Disposed 5,000 · Balance 20,554 F4: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.57, inclusive.
F3: Includes 40,080 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
F4: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2020 Filed Jan 17, 2020 16:28 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-20-000426 · primarydocument.xml · derivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,554 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 16:28 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,000 | $21.22 | $106,082.00 |
DisclosureSEC source: 0001562180-20-000426 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,170 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.57, inclusive. F3 · balance_after: Includes 40,080 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 16:28 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-20-000426 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 15:52 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 32,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000266 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,170 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date. F2 · balance_after: Includes 40,717 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · derivative · entry 9 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,554 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 6 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,740 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · balance_after: Includes 8,287 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 5 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · derivative · entry 8 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,554 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · derivative · entry 7 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,554 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 4 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,740 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,000 | $20.06 | $100,282.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,740 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.26, inclusive. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 16:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 16:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 156 | $15.82 | $2,468.08 |
DisclosureSEC source: 0001562180-19-005192 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,740 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 8,287 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. It also includes 2,000 shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2019. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 19:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004931 · primarydocument.xml · derivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,554 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 19:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001562180-19-004931 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 19:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-19-004931 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 16:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 770 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · derivative · entry 6 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,554 Underlying: Common Stock · 770 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 16:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 770 | $20.03 | $15,421.48 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 4 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.18, inclusive. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 16:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 770 | $3.96 | $3,049.20 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,930 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · derivative · entry 5 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,324 Underlying: Common Stock · 3,930 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,930 | $20.01 | $78,628.69 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.11, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 3,930 | $3.96 | $15,562.80 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004349 · primarydocument.xml · derivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,254 Underlying: Common Stock · 300 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 300 | $20.00 | $6,000.00 |
DisclosureSEC source: 0001562180-19-004349 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 300 | $3.96 | $1,188.00 |
DisclosureSEC source: 0001562180-19-004349 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2019 Filed Jul 19, 2019 14:03 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 153 | $20.00 | $3,060.00 |
DisclosureSEC source: 0001562180-19-003996 · primarydocument.xml · nonDerivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F4 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F1 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:03 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-003996 · primarydocument.xml · derivative · entry 4 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:03 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,000 | $20.01 | $100,058.00 |
DisclosureSEC source: 0001562180-19-003996 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,049 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.09, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:03 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-19-003996 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (right to buy) · Derivative | 1,111 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001562180-19-003790 · primarydocument.xml · derivative · entry 6 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,111 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (right to buy) · Derivative | 13,889 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-003790 · primarydocument.xml · derivative · entry 5 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,554 Underlying: Common Stock · 13,889 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,111 | $20.00 | $22,220.00 |
DisclosureSEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 4 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,049 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 13,889 | $20.00 | $277,780.00 |
DisclosureSEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,160 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 13,889 | $3.96 | $55,000.44 |
DisclosureSEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 1,111 | $0.84 | $937.91 |
DisclosureSEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 19:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 151 | $16.59 | $2,505.09 |
DisclosureSEC source: 0001209191-19-025165 · doc4.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,049 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 18:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantStock Option (right to purchase) · Derivative | 22,100 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004391 · doc4.xml · derivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,100 Underlying: Common Stock · 22,100 shares Expires 2029-01-15 F2 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on January 15, 2019, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 18:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004391 · doc4.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit vest in equal quarterly installments over four years commencing on January 15, 2019, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.